Outsourcing

Articles

PharmSource report addresses how the opportunity for antibody drug conjugates measures up to the bio/pharma industry’s expectations.

ADC Risk Vs. Payoff for CMO Industry

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.

Success Story: Transferring a Phytochemical API Portfolio

Agnes Shanley is senior editor of Pharmaceutical Technology.

For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.

Keeping It Simple: Collaborating for Success in Drug Delivery

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions.

Capsugel to Acquire Xcelience and Powdersize

Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.

FDA Approves Ash Stevens as API Manufacturer for Takeda’s Multiple Myeloma Drug

The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.

Cobra Biologics to Scale Production of Growth Hormone

Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.

Catalent Expands Biologics Capabilities

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

Catalent Reports Action to Restart Softgel Facility

Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.

GRAM Adds Board Member

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Better process development is creating industry benchmarks for bioprocessing.

Contract Manufacturing Services